
Dag Kvale
- Dept. head, professor II
- +47-22119153
Publications 2025
Transcriptomic and proteomic profiling reveal immune and metabolic dysregulation in the colonic mucosa of people living with HIV with incomplete immune recovery
Front Immunol, 16, 1635523
DOI 10.3389/fimmu.2025.1635523, PubMed 41041301
Publications 2023
Mortality and Sequential Organ Failure Assessment Score in Patients With Suspected Sepsis: The Impact of Acute and Preexisting Organ Failures and Infection Likelihood
Crit Care Explor, 5 (2), e0865
DOI 10.1097/CCE.0000000000000865, PubMed 36844375
Publications 2022
DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
Shock, 58 (4), 251-259
DOI 10.1097/SHK.0000000000001981, PubMed 36130401
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437
Clinical characteristics and outcomes in hospitalized adult influenza patients: an observational study from Norway 2014-2018
Infect Dis (Lond), 54 (5), 367-377
DOI 10.1080/23744235.2021.2022196, PubMed 34983302
Publications 2021
Prognostic Value of Nucleated RBCs for Patients With Suspected Sepsis in the Emergency Department: A Single-Center Prospective Cohort Study
Crit Care Explor, 3 (7), e0490
DOI 10.1097/CCE.0000000000000490, PubMed 34291222
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
Nat Commun, 12 (1), 6774
DOI 10.1038/s41467-021-27029-6, PubMed 34811370
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
Front Cell Infect Microbiol, 11, 669623
DOI 10.3389/fcimb.2021.669623, PubMed 34307194
Enhanced Gut-Homing Dynamics and Pronounced Exhaustion of Mucosal and Blood CD4+ T Cells in HIV-Infected Immunological Non-Responders
Front Immunol, 12, 744155
DOI 10.3389/fimmu.2021.744155, PubMed 34691047
[Medical education and training during a pandemic]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0581, PubMed 34505488
Publications 2020
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
Trials, 21 (1), 485
DOI 10.1186/s13063-020-04420-0, PubMed 32503662
A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
Nat Commun, 11 (1), 5284
DOI 10.1038/s41467-020-19056-6, PubMed 33082342
Publications 2017
The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study
BMC Infect Dis, 17 (1), 228
DOI 10.1186/s12879-017-2316-x, PubMed 28340570
T Cell Responses and Regulation and the Impact of In Vitro IL-10 and TGF-β Modulation During Treatment of Active Tuberculosis
Scand J Immunol, 85 (2), 138-146
DOI 10.1111/sji.12511, PubMed 27862137
Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial
PLoS One, 12 (5), e0176527
DOI 10.1371/journal.pone.0176527, PubMed 28464042
Publications 2016
Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy
PLoS One, 11 (4), e0153849
DOI 10.1371/journal.pone.0153849, PubMed 27128502
Plasma IP-10 Is Increased in Immunological NonResponders and Associated With Activated Regulatory T Cells and Persisting Low CD4 Counts
J Acquir Immune Defic Syndr, 73 (2), 138-48
DOI 10.1097/QAI.0000000000001080, PubMed 27632144
The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
BMC Infect Dis, 16 (1), 599
DOI 10.1186/s12879-016-1938-8, PubMed 27776487
Publications 2015
Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
Clin Exp Immunol, 179 (3), 454-65
DOI 10.1111/cei.12468, PubMed 25313008
Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
PLoS One, 10 (11), e0141903
DOI 10.1371/journal.pone.0141903, PubMed 26544592
High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection
J Acquir Immune Defic Syndr, 69 (4), 395-402
DOI 10.1097/QAI.0000000000000617, PubMed 26115437
Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART
J Acquir Immune Defic Syndr, 70 (4), 329-37
DOI 10.1097/QAI.0000000000000784, PubMed 26258571
IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
Sci Rep, 5, 9223
DOI 10.1038/srep09223, PubMed 25783975
IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy
J Infect, 70 (4), 381-91
DOI 10.1016/j.jinf.2014.12.019, PubMed 25597826
Publications 2014
Intranasal administration of a therapeutic HIV vaccine (Vacc-4x) induces dose-dependent systemic and mucosal immune responses in a randomized controlled trial
PLoS One, 9 (11), e112556
DOI 10.1371/journal.pone.0112556, PubMed 25398137
Comparable Cellular Immune Responses in Patients with and without Antiretroviral Treatment after Immunization with HIV-1 P24, P17 and Tat Consensus Peptides (Vacc-5q)
J AIDS Clin Res, 5 (4), 1000294
DOI 10.4172/2155-6113.1000296, PublikaID 217
A parameter for IL-10 and TGF-ß mediated regulation of HIV-1 specific T cell activation provides novel information and relates to progression markers
PLoS One, 9 (1), e85604
DOI 10.1371/journal.pone.0085604, PubMed 24416431
Plasma lipopolysaccharide and triglycerides are independently associated and both markers correlate with the development of metabolic syndrome in HIV infection
J Acquir Immune Defic Syndr, 65 (4), e158-61
DOI 10.1097/QAI.0000000000000055, PubMed 24577189
Monocyte activation, but not microbial translocation, is independently associated with markers of endovascular dysfunction in HIV-infected patients receiving cART
J Acquir Immune Defic Syndr, 67 (4), 370-4
DOI 10.1097/QAI.0000000000000339, PubMed 25226210
Microbial translocation and cardiometabolic risk factors in HIV infection
AIDS Res Hum Retroviruses, 30 (6), 514-22
DOI 10.1089/aid.2013.0280, PubMed 24521167
Publications 2013
A web-based intervention trial for depressive symptoms and subjective well-being in patients with chronic HIV infection
AIDS Care, 26 (9), 1080-9
DOI 10.1080/09540121.2013.869541, PubMed 24359563
Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses
PLoS One, 8 (7), e69896
DOI 10.1371/journal.pone.0069896, PubMed 23875007
Boosters of a therapeutic HIV-1 vaccine induce divergent T cell responses related to regulatory mechanisms
Vaccine, 31 (41), 4611-8
DOI 10.1016/j.vaccine.2013.07.037, PubMed 23906886
Markers of microbial translocation predict hypertension in HIV-infected individuals
HIV Med, 14 (6), 354-61
DOI 10.1111/hiv.12015, PubMed 23332095
Microbial translocation in HIV infection is associated with dyslipidemia, insulin resistance, and risk of myocardial infarction
J Acquir Immune Defic Syndr, 64 (5), 425-33
DOI 10.1097/QAI.0b013e31829f919d, PubMed 23797689
Bayesian estimation of HIV-1 dynamics in vivo
Math Med Biol, 32 (1), 38-55
DOI 10.1093/imammb/dqt018, PubMed 24078026
Publications 2012
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania
Int J Infect Dis, 16 (12), e879-85
DOI 10.1016/j.ijid.2012.08.003, PubMed 23031419
Intradermal vaccination of HIV-infected patients with short HIV Gag p24-like peptides induces CD4 + and CD8 + T cell responses lasting more than seven years
Scand J Infect Dis, 44 (8), 566-72
DOI 10.3109/00365548.2011.653581, PubMed 22339485
Circulating levels of HMGB1 are correlated strongly with MD2 in HIV-infection: possible implication for TLR4-signalling and chronic immune activation
Innate Immun, 19 (3), 290-7
DOI 10.1177/1753425912461042, PubMed 23070967
Publications 2011
Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
APMIS, 120 (3), 204-9
DOI 10.1111/j.1600-0463.2011.02843.x, PubMed 22339677
An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses
J Virol, 85 (13), 6557-66
DOI 10.1128/JVI.00073-11, PubMed 21490090
Publications 2010
Low frequency of amino acid alterations following therapeutic immunization with HIV-1 Gag p24-like peptides
AIDS, 24 (17), 2609-18
DOI 10.1097/QAD.0b013e32833e502b, PubMed 20935558
Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection
Clin Exp Immunol, 161 (2), 315-23
DOI 10.1111/j.1365-2249.2010.04179.x, PubMed 20491784
Publications 2009
Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
J Antimicrob Chemother, 64 (5), 901-9
DOI 10.1093/jac/dkp316, PubMed 19740910
Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity
Scand J Infect Dis, 41 (11-12), 808-17
DOI 10.3109/00365540903186181, PubMed 19922062
Interleukin-10-secreting T cells define a suppressive subset within the HIV-1-specific T-cell population
Eur J Immunol, 39 (5), 1280-7
DOI 10.1002/eji.200839002, PubMed 19384871
Publications 2008
PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples
Curr HIV Res, 6 (1), 49-58
DOI 10.2174/157016208783571955, PubMed 18288975
Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment
J Infect Dis, 198 (10), 1474-81
DOI 10.1086/592713, PubMed 18851688
Publications 2007
Insulin resistance is affected by increased levels of plasma lactate but not mitochondrial alterations in skeletal muscle in NRTI-exposed HIV-infected patients
HIV Clin Trials, 8 (5), 345-53
DOI 10.1310/hct0805-345, PubMed 17956836
Publications 2006
[Immunopathogenesis and therapeutic immunization in HIV-infection]
Tidsskr Nor Laegeforen, 126 (23), 3112-6
PubMed 17160117
Long-term HIV-specific responses and delayed resumption of antiretroviral therapy after peptide immunization targeting dendritic cells
AIDS, 20 (4), 627-30
DOI 10.1097/01.aids.0000210620.75707.ac, PubMed 16470131
Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment
AIDS, 20 (6), 813-20
DOI 10.1097/01.aids.0000218544.54586.f1, PubMed 16549964
Publications 2005
Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease
Haematologica, 90 (1), 86-93
PubMed 15642674
Reduced viral burden amongst high responder patients following HIV-1 p24 peptide-based therapeutic immunization
Vaccine, 23 (31), 4011-5
DOI 10.1016/j.vaccine.2005.03.010, PubMed 15963359
Divergent in vitro and in vivo correlates of HIV-specific T-cell responses during onset of HIV viraemia
AIDS, 19 (6), 563-7
DOI 10.1097/01.aids.0000163932.76531.c6, PubMed 15802974
Multiple antigen concentrations in delayed-type hypersensitivity (DTH) and response diversity during and after immunization with a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
Vaccine, 24 (10), 1543-50
DOI 10.1016/j.vaccine.2005.10.012, PubMed 16289707
Publications 2004
HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vacc-4x)
AIDS, 18 (14), 1875-83
DOI 10.1097/00002030-200409240-00003, PubMed 15353973
Publications 2002
Predictive value of immunologic parameters and HIV RNA in relation to humoral pneumococcal polysaccharide vaccine responses in patients with HIV infection
Eur J Clin Microbiol Infect Dis, 21 (9), 688-90
DOI 10.1007/s10096-002-0803-4, PubMed 12373505
Immunophenotypic analyses of CD34(+) cell subsets in bone marrow from HIV-infected patients during highly- active antiretroviral therapy
Eur J Clin Invest, 32 (7), 535-40
DOI 10.1046/j.1365-2362.2002.00995.x, PubMed 12153555
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Clin Microbiol Infect, 8 (7), 431-4
DOI 10.1046/j.1469-0691.2002.00449.x, PubMed 12199854
Publications 2000
Human intestinal endothelium shows high susceptibility to cytomegalovirus and altered expression of adhesion molecules after infection
Scand J Immunol, 51 (4), 354-60
DOI 10.1046/j.1365-3083.2000.00676.x, PubMed 10736107
Publications 1999
Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure
J Infect Dis, 179 (1), 74-82
DOI 10.1086/314572, PubMed 9841825
CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS
AIDS, 13 (2), 195-201
DOI 10.1097/00002030-199902040-00007, PubMed 10202825
Different regulatory pathways employed in cytokine-enhanced expression of secretory component and epithelial HLA class I genes
Eur J Immunol, 29 (1), 168-79
DOI 10.1002/(SICI)1521-4141(199901)29:01<168::AID-IMMU168>3.0.CO;2-8, PubMed 9933098
IL-10 in HIV infection: increasing serum IL-10 levels with disease progression--down-regulatory effect of potent anti-retroviral therapy
Clin Exp Immunol, 116 (1), 115-20
DOI 10.1046/j.1365-2249.1999.00865.x, PubMed 10209514
Publications 1998
Major histocompatibility complex class II-dependent antigen presentation by human intestinal endothelial cells
Gastroenterology, 114 (4), 649-56
DOI 10.1016/s0016-5085(98)70578-5, PubMed 9516385
Publications 1997
Topographic distribution of homing receptors on B and T cells in human gut-associated lymphoid tissue: relation of L-selectin and integrin alpha 4 beta 7 to naive and memory phenotypes
Am J Pathol, 150 (1), 187-99
PubMed 9006335
[Q-fever imported into Norway]
Tidsskr Nor Laegeforen, 117 (27), 3937-40
PubMed 9441420
Publications 1996
Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells
J Immunol, 156 (7), 2558-65
PubMed 8786319
Intercellular adhesion molecule-1 (ICAM-1; CD54) expression in human hepatocytic cells depends on protein kinase C
J Hepatol, 25 (5), 670-6
DOI 10.1016/s0168-8278(96)80237-6, PubMed 8938544
Publications 1995
Isolation and longterm culture of human intestinal microvascular endothelial cells
Gut, 37 (2), 225-34
DOI 10.1136/gut.37.2.225, PubMed 7557573
Cloning, chromosomal localization, and linkage analysis of the gene encoding human transmembrane secretory component (the poly-Ig receptor)
Adv Exp Med Biol, 371A, 617-23
DOI 10.1007/978-1-4615-1941-6_130, PubMed 8526003
Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29
Gut, 36 (5), 737-42
DOI 10.1136/gut.36.5.737, PubMed 7797124
Butyrate differentially affects constitutive and cytokine-induced expression of HLA molecules, secretory component (SC), and ICAM-1 in a colonic epithelial cell line (HT-29, clone m3)
Adv Exp Med Biol, 371A, 183-8
DOI 10.1007/978-1-4615-1941-6_37, PubMed 8525902
Publications 1994
Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines
Anticancer Res, 14 (6B), 2445-51
PubMed 7872665
SpeedGenie: demo guide : Windows version 1.1 : sequence database searching software
MedProbe, Oslo, 73 s.
BIBSYS 950678996
SpeedGenie User's Guide
MedProbe, Oslo, 89 s.
PublikaID 45
Publications 1993
Interferon-gamma stimulation of messenger RNA for human secretory component (poly-Ig receptor) depends on continuous intermediate protein synthesis
Scand J Immunol, 37 (2), 251-6
DOI 10.1111/j.1365-3083.1993.tb01763.x, PubMed 8434236
Immune modulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human hepatocytic cell lines
J Hepatol, 17 (3), 347-52
DOI 10.1016/s0168-8278(05)80216-8, PubMed 7686194
Publications 1992
Epithelial expression of HLA, secretory component (poly-Ig receptor), and adhesion molecules in the human alimentary tract
Ann N Y Acad Sci, 664, 157-79
DOI 10.1111/j.1749-6632.1992.tb39758.x, PubMed 1456647
EPITHELIAL EXPRESSION OF HLA, SECRETORY COMPONENT (POLY-IG RECEPTOR), AND ADHESION MOLECULES IN THE HUMAN ALIMENTARY-TRACT
Ann.NY Acad.Sci., 664, 157-179
DOI 10.1111/j.1749-6632.1992.tb39758.x
Molecular cloning and exon-intron mapping of the gene encoding human transmembrane secretory component (the poly-Ig receptor)
Eur J Immunol, 22 (9), 2309-15
DOI 10.1002/eji.1830220920, PubMed 1355431
Expression and regulation of adhesion molecules ICAM-1 (CD54) and LFA-3 (CD58) in human intestinal epithelial cell lines
Scand J Immunol, 35 (6), 669-76
DOI 10.1111/j.1365-3083.1992.tb02973.x, PubMed 1376489
Circulating secretory component in relation to early diagnosis and treatment of liver metastasis from colorectal carcinomas
J Clin Pathol, 45 (7), 568-71
DOI 10.1136/jcp.45.7.568, PubMed 1517455
Publications 1991
[Symptomatic cytomegalovirus infection in patients with acquired immunodeficiency syndrome]
Tidsskr Nor Laegeforen, 111 (28), 3379-84
PubMed 1665253
Publications 1990
The significance of anti-hepatitis C virus antibodies measured in chronic liver disease
Scand J Gastroenterol, 25 (11), 1169-74
DOI 10.3109/00365529008998550, PubMed 2177219
Protein kinase C activation selectively increases mRNA levels for one of the regulatory subunits (RI alpha) of cAMP-dependent protein kinases in HT-29 cells
Biochem Biophys Res Commun, 172 (2), 409-14
DOI 10.1016/0006-291x(90)90688-j, PubMed 2241943
Publications 1989
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes
Gastroenterology, 97 (6), 1562-84
DOI 10.1016/0016-5085(89)90406-x, PubMed 2684725
PHYSIOLOGY AND IMMUNOPATHOLOGY OF THE INTESTINAL SECRETORY IMMUNE-SYSTEM
Ital. J. Gastroenterol., 21 (1), 21-34
Human secretory component: cellular studies and clinical applications for patients with cancer and liver disease
Dag Kvale, Oslo, 1 b. (flere pag.)
BIBSYS 890177198, ISBN 82-90187-47-5
[New biotechnologic products in treatment and prevention]
Tidsskr Nor Laegeforen, 109 (33), 3427-30
PubMed 2609304
Publications 1988
The poly-Ig receptor--functional aspects of secretory component expression
Adv Exp Med Biol, 237, 9-20
DOI 10.1007/978-1-4684-5535-9_2, PubMed 3151046
Interactions of lymphoid cells with the epithelial environment
Monogr Allergy, 24, 51-9
PubMed 3163099
Lymphoepithelial interactions in the mucosal immune system
Gut, 29 (8), 1116-30
DOI 10.1136/gut.29.8.1116, PubMed 3044933
Rapid selection of cultured cells with increased expression of a membrane marker (secretory component)
Int J Cancer, 42 (4), 638-41
DOI 10.1002/ijc.2910420428, PubMed 2459074
Does secretory component (SC) exist as free SC in human serum?
J Immunol Methods, 113 (2), 279-81, 87-88
DOI 10.1016/0022-1759(88)90342-0, PubMed 3171192
FREE SECRETORY COMPONENT IN HUMAN-SERUM - REPLY
J. Immunol. Methods, 113 (2), 287-288
DOI 10.1016/0022-1759(88)90344-4
Up-regulation of the expression of secretory component and HLA molecules in a human colonic cell line by tumour necrosis factor-alpha and gamma interferon
Scand J Immunol, 28 (3), 351-7
DOI 10.1111/j.1365-3083.1988.tb01460.x, PubMed 3143150
Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig
J Immunol, 140 (9), 3086-9
PubMed 3361127
T cell-epithelium interactions in relation to gut immunity
Monogr Allergy, 24, 60-5
PubMed 3129651
Publications 1987
Production and secretion of immunoglobulins in the gastrointestinal tract
Ann Allergy, 59 (5 Pt 2), 21-39
PubMed 3318585
Reaction to the article: ELISA for measurement of secretory IgA distinct from monomeric IgA
J Immunol Methods, 103 (1), 147-50
DOI 10.1016/0022-1759(87)90254-7, PubMed 3655382
Relation between circulating secretory component (SC) and liver metastasis of colonic or mammary carcinoma
Adv Exp Med Biol, 216B, 1101-7
PubMed 3425420
Early detection of liver metastasis in patients with colorectal carcinoma by increased levels of circulating IgA- and IgM-associated secretory component
Br J Cancer, 56 (5), 629-32
DOI 10.1038/bjc.1987.256, PubMed 3426927
Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis
Cancer, 59 (2), 203-7
DOI 10.1002/1097-0142(19870115)59:2<203::aid-cncr2820590204>3.0.co;2-p, PubMed 3802011
Circulating secretory component in breast neoplasms
J Clin Pathol, 40 (6), 621-5
DOI 10.1136/jcp.40.6.621, PubMed 3301907
Circulating secretory immunoglobulins of the A and M isotypes in chronic liver disease
J Hepatol, 4 (2), 229-35
DOI 10.1016/s0168-8278(87)80085-5, PubMed 3584932
Induction of various HLA class II molecules in a human colonic adenocarcinoma cell line
Scand J Immunol, 25 (2), 175-80
DOI 10.1111/j.1365-3083.1987.tb01061.x, PubMed 2434988
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins
J Immunol, 138 (12), 4303-6
PubMed 3108385
Synthesis of cytoplasmic and functional membrane SC induced by gamma-interferon
Adv Exp Med Biol, 216B, 1109-16
PubMed 3122531
Publications 1986
An enzyme-linked immunosorbent assay for differential quantitation of secretory immunoglobulins of the A and M isotypes in human serum
J Immunol Methods, 86 (1), 107-14
DOI 10.1016/0022-1759(86)90272-3, PubMed 3944464